N-Boc-2,5-Dihydro-3-Ethynyl-1-H-Pyrrole

A reactivity profile defined by the terminal alkyne at the C-3 position of the N-Boc-protected 2,5-dihydropyrrole ring creates a discrete set of downstream insertion points in fine chemical manufacturing. Commercial batches assayed at ≥97% purity (GC-FID, area%) and stored under argon at 2–8 °C exhibit negligible homocoupling byproducts over 12-month shelf life when residual palladium is controlled below 50 ppm. The simultaneous presence of a latent primary amine (via TFA or HCl deprotection) and a Cu(I)-reactive alkyne governs process fits across small-molecule drug substance production, targeted protein degrader assembly, covalent polymer network formation, and bioorthogonal probe synthesis. Variations in the stereoelectronic environment at nitrogen demand tight pH control during Boc removal to avoid pyrroline isomerisation, a failure mode frequently reported on pilot-plant scale when quench temperature exceeds 15°C.

When residual acetylide homocoupling competes with Sonogashira cross-coupling in late-stage API functionalisation

The compound is incorporated as a bifunctional C–C bond-forming handle during the construction of pyrrolidine-containing active pharmaceutical ingredients where a saturated azacycle is pharmacophoric. Process development chemists routinely optimise the Sonogashira coupling between the terminal alkyne and a heteroaryl bromide or iodide to avoid Glaser-type oxidative dimerisation, an undesired pathway that intensifies at dissolved O₂ levels above 5 ppm. Standard operating protocols from multi-kilo campaigns specify degassing with argon/nitrogen through a sintered sparger for ≥45 minutes before addition of 0.5–2.0 mol% Pd(PPh₃)₂Cl₂ and 1.0–2.0 mol% CuI. The N-Boc-pyrroline alkyne is charged at a molar ratio of 1.05–1.30 relative to the limiting aryl halide to compensate for alkyne consumption via protodecupration, a stoichiometric drift documented in batch records when reaction mass temperature fluctuates beyond ±3°C from the setpoint of 50°C. Subsequent Boc-deprotection employing 4.0 M HCl in dioxane or a 1:1 (v/v) TFA/DCM mixture liberates the pyrroline amine, which is immediately trapped as a hydrochloride salt or acylated to construct the final drug substance. Compliance with ICH Q7 is applied at the intermediate stage; residual Pd must not exceed 10 ppm per USP <232> when the product is designated as a late intermediate intended for Phase III or commercial filings. Terminal product classes include renin inhibitors, kappa opioid receptor modulators, and selective serotonin reuptake inhibitors that utilise the 3-substituted pyrrolidine scaffold as a conformational constraint. Representative molecular weight contributions of the N-Boc-alkyne fragment in the final deprotected API range from 9–22 wt%, depending on whether the final amine is presented as a secondary or tertiary centre.

A parallel processing route encountered in kilo-lab environments exploits the acetylene function without metal catalysis. The alkynyl moiety undergoes thermal or copper-mediated [3+2] cycloaddition with azide-bearing glycosides or polyethylene glycol chains to generate 1,2,3-triazole-linked conjugates. This protocol has been validated for the synthesis of candidate antiviral nucleosides where the triazole acts as a metabolically stable phosphate bridge mimic. The step demands strict anhydrous conditions; Karl Fischer titration of the reaction mixture must read <50 µg/mL water to suppress azide protonation and subsequent Curtius-type degradation. In this context the N-Boc intermediate is used at 1.0–1.2 equivalents relative to the azide component. The downstream process train couples the click reaction directly with a liquid-liquid extraction against 10% w/w aqueous NH₄Cl adjusted to pH 8.5, followed by crystallisation from methyl tert-butyl ether/n-heptane. Terminal products are N-Boc-triazole-prodrugs that undergo in vivo esterase activation, assessed per ISO 10993-1:2018 biocompatibility frameworks when intended for parenteral administration.

What governs CuAAC efficiency when the N-Boc-pyrroline alkyne serves as the linker attachment point in VHL- and CRBN-recruiting PROTACs?

Heterobifunctional degrader assembly leverages N-Boc-2,5-dihydro-3-ethynyl-1-H-pyrrole as a conformationally restricted alkyne linker precursor. The sp²-hybridised pyrroline introduces a kink angle dissimilar to linear propargyl amines, which influences ternary complex formation kinetics. In medicinal chemistry workflows, the copper-catalysed azide-alkyne cycloaddition (CuAAC) is performed using the N-Boc-protected form to prevent Cu(I) sequestration by the basic pyrroline nitrogen, which would otherwise form an inactive metal-amine complex. Standard conditions employ 1.5–2.5 equivalents of the N-Boc alkyne relative to the azide-derivatised warhead ligand, 0.1–0.2 equivalents of CuSO₄·5H₂O, and 0.5–1.0 equivalents of sodium ascorbate in a degassed 1:1 t-BuOH/H₂O mixture at 25–35°C. The Boc group is subsequently removed with 25% TFA in DCM to expose the pyrroline amine, which is directly coupled to a carboxylic-acid-terminated E3 ligase ligand via HATU/DIPEA-mediated amidation. Final PROTAC purity specifications, aligned with the Ph. Eur. monograph 2.2.46 for chromatographic separation techniques, require detection of the de-Boc impurity at a reporting threshold of 0.10% area. Weight percentage contributions of the N-Boc-pyrroline fragment to the fully deprotected degrader molecule typically fall in the 18–31 wt% window, a value that modulates logD and passive permeability as measured by PAMPA assay (pION PSR4p instrument) at pH 7.4. Terminal products target oncogenic kinases (BTK, ALK, BCR-ABL) and nuclear hormone receptors (AR, ER) and are handled under ICH M7(R2) control limits for mutagenic impurities; the alkyne itself has been tested in a standard Ames fluctuation assay (OECD 471) and found non-mutagenic at 5000 µg/plate.

Scaling the CuAAC step beyond 500 g input alkyne has revealed a kinetic bottleneck: the triazole product itself chelates Cu(I) when the pyrroline is deprotected prematurely, causing a stalled reaction at 65–80% conversion. At production scale this phenomenon is mitigated by maintaining Boc integrity through a pH stat control that keeps the aqueous phase below pH 6.0 via continuous addition of 1.0 M acetic acid. Equipment configuration must avoid stainless steel vessels with nickel content above 8%; observed nickel leaching at 0.3–0.5 ppm under acidic conditions catalyses alkyne oligomerisation and generates black particulates requiring subsequent hot-filtration through a 0.5 µm PTFE membrane. These processing constraints substantially define the cost-in-use economics for degrader candidates in preclinical development, with overall yield from alkyne to final PROTAC typically not exceeding 55–65% over three telescoped stages.

Bioorthogonal Imaging Probes: Photostability and Solubility Trade-offs

Incorporation of the N-Boc-alkyne into fluorogenic tetrazine-alkyne inverse electron-demand Diels–Alder (IEDDA) constructs exploits the quenching effect of the electron-deficient pyrroline until cycloaddition restores the extended π-system. That application class demands the alkyne be used in a pre-Boc-deprotection state at stoichiometric ratios of 1.0:1.0 with a tetrazine-appended BODIPY, Cy5, or Si-rhodamine dye in anhydrous DMSO or acetonitrile under argon. The product fluorophore is separated via preparative HPLC with a 0.1% TFA modifier, as the acid-labile Boc survives only when column temperature is maintained strictly below 30°C and contact time with acidic mobile phase is kept under 15 minutes. At higher residence times, partial deprotection yields a free amine that re-acts with residual tetrazine and produces a non-fluorescent dead-end adduct. The residual Boc-protected dye is formulated in sterile PBS for confocal and super-resolution microscopy, validated against ISO 21073:2019 guidelines for microscope test performance. The final formulation incorporates the fluorophore at nanomolar loading (100–500 nM), with the N-Boc fragment contributing roughly 4–8% of the conjugate molecular mass. End products are targeted mitochondrial, lysosomal, or membrane-localisation probes delivered to academic imaging core facilities and early drug-discovery target engagement assays. Staining protocols explicitly require pre-dilution in dry DMSO; adventitious water levels above 0.1% v/v induce dye aggregation detectable by dynamic light scattering as a shift in Z-average diameter from 3–5 nm to 70–120 nm.

Polymer chemistry scenarios utilise the same terminal acetylene in a fundamentally different kinetic regime. The N-Boc-pyrroline alkyne is homopolymerised or copolymerised with di-azide monomers under CuAAC conditions to generate linear polytriazoles or crosslinked organogels. In step-growth polymerisation, the compound is charged at a precise stoichiometric imbalance of 1.000:1.005 (alkyne:azide) to achieve a number-average molecular weight near 25,000 g/mol as determined by GPC-MALLS using the dn/dc value 0.185 mL/g in DMF. The solution polymerisation is conducted at 40°C under a nitrogen blanket in a glass-lined reactor equipped with a pitched-blade turbine impeller at 150 rpm, with the catalyst Cu(PPh₃)₃Br loaded at 0.5 mol%. Post-polymerisation, the polymeric Boc groups are removed with formic acid to expose pendant secondary amines, producing a cationic polyelectrolyte used in layer-by-layer deposition for biosensor interfaces. Compliance with REACH Article 56 and the European Chemicals Agency’s guidance on polymers of low concern applies because the final deprotected polymer backbone exhibits an Mn above 10,000 g/mol and contains less than 2% oligomeric species below 1000 g/mol. Terminal products are ultrathin antimicrobial coatings on indium tin oxide substrates, with the coating formulation comprising 0.5–1.0 wt% polymer in 0.2 M acetate buffer at pH 4.5.

Corrosion Inhibitor Intermediates in Copper-Wafer CMP Slurries: Controlling Dishing and Erosion with Heterocyclic Alkynes

An adjacent industrial segment evaluates the N-Boc alkyne as a transient metal-surface passivator precursor in chemical–mechanical planarisation (CMP) slurries for copper damascene processing at the 14 nm node and below. The terminal alkyne chemisorbs onto Cu(0) surfaces through π-dative bonding, forming a monomolecular protective film that suppresses static etch rates to <2 nm/min while permitting abrasive-facilitated removal at 50–80 nm/min under nominal downforce of 1.5 psi on a rotary polisher with an IC1000 pad. The Boc group provides transient aqueous dispersibility; upon contact with the slightly acidic slurry medium (pH 5.0–5.5, adjusted with succinic acid), slow deprotection releases the free amine, which protonates and desorbs from the copper surface, enabling a self-limiting passivation mechanism. Typical slurry formulations incorporate the N-Boc alkyne at 0.05–0.2 wt% along with 1.0 wt% colloidal silica abrasive (primary particle diameter 35 nm, KOH-stabilised) and 0.5 wt% hydrogen peroxide. The compliance dossier references SEMI standard C61-0322 for copper CMP slurry performance and IPC J-STD-001F for cleanliness requirements on finished wafers. End products are patterned 300-mm wafers with post-CMP dishing below 10 nm on isolated 50 µm lines measured by atomic force profilometry. Published data for this specific configuration is limited to preliminary pad-life studies where the organic additive demonstrated no significant degradation over 12 hours of continuous circulation, as monitored by total organic carbon analysis.

A separate quality-critical application for N-Boc-2,5-dihydro-3-ethynyl-1-H-pyrrole resides in the synthesis of acetylide-bridged diruthenium mixed-valence complexes for near-IR electrochromic devices. The compound is deprotonated using lithium diisopropylamide at −78°C in THF and transmetallated onto a RuCl₂(dppe)₂ fragment at a strict alkyne-to-ruthenium stoichiometry of 2.1:1.0 to ensure full conversion of the metal precursor. The resulting Ru-alkynyl complex precipitates upon addition of hexane and is recrystallised from 1:4 DCM/hexane under strictly oxygen-free conditions (<5 ppm O₂). The Boc-pyrroline ancillary ligand is retained through the subsequent electrochemical conditioning cycle; cyclic voltammograms recorded in 0.1 M tetrabutylammonium hexafluorophosphate in acetonitrile exhibit a reversible one-electron oxidation at +0.42 V vs. Fc/Fc⁺, a potential that shifts anodically by 60–80 mV upon deprotection due to amine protonation altering the donor properties. The deposited film achieves an optical contrast ratio exceeding 60% at 1550 nm between coloured and bleached states, per measurement protocol derived from ASTM E1331-15. The terminal device is a laminated electrochromic cell with a lithium polymer electrolyte intended for variable-transmittance architectural glazing, with the device passing accelerated ageing at 80°C and 85% relative humidity for 1200 hours in accordance with EN 1279-3:2018.

During kilogram-scale isolation for the pharma-probe intersection, a recurrent deviation involves the generation of a purple chromophore (λ_max = 537 nm) originating from trace iron acetylide formation when the reaction mixture contacts unpassivated stainless steel transfer lines. The iron complex is not retained by standard silica plug filtration and co-elutes with the product during preparative chromatography if the mobile phase lacks 0.01% w/v EDTA disodium salt. This behaviour imposes a definitive stainless steel incompatibility for all alkynes handled in protonated form; post-manufacture transfer lines, storage tanks, and reactor jackets are specified in Hastelloy C-276 or glass-lined carbon steel. The required equipment investment constrains the economic production scale to 500–800 kg per annum per facility design specification.